BioVie (BIVI)
(Delayed Data from NSDQ)
$1.79 USD
-0.01 (-0.67%)
Updated Sep 26, 2025 09:44 AM ET
2-Buy of 5 2
D Value C Growth A Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
BIVI 1.79 -0.01(-0.67%)
Will BIVI be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for BIVI based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for BIVI
20 Day Moving Average Support appears for BIVI after 3.23% move
BIVI forms Shooting Star Candlestick on September 24
The technical outlook for BIVI is unchanged after it falls 2.65% on September 23
BIVI rises 1.61% on September 22, leaving the technical picture intact
BIVI forms NR7 on September 20